{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:13:04Z","timestamp":1772039584463,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T00:00:00Z","timestamp":1305763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2407-11-182","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T06:16:20Z","timestamp":1305872180000},"source":"Crossref","is-referenced-by-count":23,"title":["Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT"],"prefix":"10.1186","volume":"11","author":[{"given":"Alexandra D","family":"Jensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Potthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almaz","family":"Desta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Habl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Mavtratzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Windemuth-Kiesselbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc W","family":"M\u00fcnter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,19]]},"reference":[{"key":"2675_CR1","unstructured":"NCCN guidelines for physicians as accessed on 12.12.2010 on. [ http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/head-and-neck.pdf ]"},{"key":"2675_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","volume":"355","author":"JP Pignon","year":"2000","unstructured":"Pignon JP, Bourhis J, Domenge C, Designe L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000, 355: 949-955.","journal-title":"Lancet"},{"key":"2675_CR3","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.ijrobp.2007.04.088","volume":"69","author":"JP Pignon","year":"2007","unstructured":"Pignon JP, le Maitre A, Bourhis J: MACH-NC collaborative group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys. 2007, 69: S112-114.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2675_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon JP, le Maitre A, Maillard E, Bourhis J: MACH-NC collaborative group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009, 92: 4-14. 10.1016\/j.radonc.2009.04.014.","journal-title":"Radiother Oncol"},{"key":"2675_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2407-6-28","volume":"6","author":"W Budach","year":"2006","unstructured":"Budach W, Hehr T, Budach V, Belka C, Dietz K: A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected lically advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2006, 6: 28-10.1186\/1471-2407-6-28.","journal-title":"BMC Cancer"},{"key":"2675_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","volume":"368","author":"J Bourhis","year":"2006","unstructured":"Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Ma\u00eetre A, Pajak TF, Poulsen MG, O'Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LH, Fallai C, Fu KK, Sylvester R, Pignon JP: Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006, 368: 843-854. 10.1016\/S0140-6736(06)69121-6.","journal-title":"Lancet"},{"key":"2675_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","volume":"48","author":"KK Fu","year":"2000","unstructured":"Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK: A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000, 48: 7-16. 10.1016\/S0360-3016(00)00663-5.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2675_CR8","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","volume":"91","author":"G Calais","year":"1999","unstructured":"Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999, 91: 2081-2086. 10.1093\/jnci\/91.24.2081.","journal-title":"J Natl Cancer Inst"},{"key":"2675_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, Wagner H, Kish JA, Ensley JF, Schuller DE, Forastiere AA: An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003, 21: 92-98. 10.1200\/JCO.2003.01.008.","journal-title":"J Clin Oncol"},{"key":"2675_CR10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","volume":"16","author":"M Al-Sarraf","year":"1998","unstructured":"Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol. 1998, 16: 1310-1317.","journal-title":"J Clin Oncol"},{"key":"2675_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0360-3016(03)01437-8","volume":"58","author":"MW M\u00fcnter","year":"2004","unstructured":"M\u00fcnter MW, Karger CP, Hoefner SG, Hof H, Thilmann C, Rudat V, Nill S, Wannenmacher M, Debus J: Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys. 2004, 58: 175-184. 10.1016\/S0360-3016(03)01437-8.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2675_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0167-8140(01)00449-2","volume":"61","author":"KS Chao","year":"2001","unstructured":"Chao KS, Majhail N, Huang CJ, Simpson JR, Perez CA, Haughey B, Spector G: Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001, 61: 275-280. 10.1016\/S0167-8140(01)00449-2.","journal-title":"Radiother Oncol"},{"key":"2675_CR13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","volume":"66","author":"EH Pow","year":"2006","unstructured":"Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, Leung WK: Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006, 66: 981-991. 10.1016\/j.ijrobp.2006.06.013.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2675_CR14","volume-title":"Proc ASCO","author":"C Nutting","year":"2009","unstructured":"Nutting C, A'Hern R, Rogers MS, Sydenham MA, Adab F, Harrington K, Jefferies S, Scrase C, Yap BK, Hall E: On behalf of the PARSPORT Trial Management Group. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) vs conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK\/03\/005). Proc ASCO. 2009, abstr.# LBA6006"},{"issue":"2","key":"2675_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cncr.21158","volume":"104","author":"D Schulz-Ertner","year":"2005","unstructured":"Schulz-Ertner D, Nikoghosyan A, Didinger B, Munter M, Jakel O, Karger CP, Debus J: Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer. 2005, 104 (2): 338-44. 10.1002\/cncr.21158.","journal-title":"Cancer"},{"key":"2675_CR16","doi-asserted-by":"crossref","first-page":"e16010","DOI":"10.1200\/jco.2010.28.15_suppl.e16010","volume":"28","author":"M M\u00fcnter","year":"2010","unstructured":"M\u00fcnter M, Umathum V, Jensen AD, Hof H, Jaekel O, Debus J: Combination of intensity-modulated radiation therapy (IMRT) and a heavy ion (C12) boost for subtotal resected or inoperable adenoid cystic carcinomas (ACCs) of the head and neck region. J Clin Oncol. 2010, 28: e16010-","journal-title":"J Clin Oncol"},{"key":"2675_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2006.12.059","volume":"68","author":"D Schulz-Ertner","year":"2007","unstructured":"Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jakel O, Edler L, Scholz M, Debus J: Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys. 2007, 68: 449-57. 10.1016\/j.ijrobp.2006.12.059.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2675_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijrobp.2006.08.027","volume":"67","author":"D Schulz-Ertner","year":"2007","unstructured":"Schulz-Ertner D, Nikoghosyan A, Hof H, Didinger B, Combs SE, J\u00e4kel O, Karger CP, Edler L, Debus J: Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys. 2007, 67: 171-177. 10.1016\/j.ijrobp.2006.08.027.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2675_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006, 354: 567-578. 10.1056\/NEJMoa053422.","journal-title":"N Engl J Med"},{"key":"2675_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","volume":"11","author":"JA Bonner","year":"2010","unstructured":"Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK: Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010, 11: 21-28. 10.1016\/S1470-2045(09)70311-0.","journal-title":"Lancet Oncol"},{"key":"2675_CR21","first-page":"7350","volume":"62","author":"KK Ang","year":"2002","unstructured":"Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L: Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002, 62: 7350-7356.","journal-title":"Cancer Res"},{"key":"2675_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ijrobp.2007.10.040","volume":"71","author":"JJ Caudell","year":"2008","unstructured":"Caudell JJ, Sawrie SM, Spencer SA, Desmoid RA, Carroll WR, Peters GE, Nabell LM, Meredith RF, Bonner JA: Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetucimab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys. 2008, 71: 676-681. 10.1016\/j.ijrobp.2007.10.040.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2675_CR23","first-page":"4637","volume":"53","author":"Z Fan","year":"1993","unstructured":"Fan Z, Baselga J, Masui H, Medelsohn J: Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-deamminedichloroplatinum on well established A431 cell xenografts. Cancer Res. 1993, 53: 4637-4642.","journal-title":"Cancer Res"},{"key":"2675_CR24","first-page":"701","volume":"6","author":"L Milas","year":"2000","unstructured":"Milas L, Mason K, Hunter N, Petersen S, Yamakawa M, Ang K, Mendelsohn J, Fan Z: In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res. 2000, 6: 701-708.","journal-title":"Clin Cancer Res"},{"key":"2675_CR25","first-page":"1935","volume":"59","author":"SM Huang","year":"1999","unstructured":"Huang SM, Bock JM, Harari PM: Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinoma of the head and neck. Cancer Res. 1999, 59: 1935-1940.","journal-title":"Cancer Res"},{"key":"2675_CR26","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa070956","volume":"357","author":"MR Posner","year":"2007","unstructured":"Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM, Haddad RI: TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007, 357: 1705-15. 10.1056\/NEJMoa070956.","journal-title":"N Engl J Med"},{"key":"2675_CR27","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"JB Vermorken","year":"2007","unstructured":"Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL: EORTC 24971\/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007, 357: 1695-704. 10.1056\/NEJMoa071028.","journal-title":"N Engl J Med"},{"key":"2675_CR28","doi-asserted-by":"publisher","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","volume":"23","author":"R Hitt","year":"2005","unstructured":"Hitt R, Lopez-Pousa A, Martinez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Mart\u00ed JL, Lobo F, Pastor P, Valent\u00ed V, Bel\u00f3n J, S\u00e1nchez MA, Chaib C, Pallar\u00e9s C, Ant\u00f3n A, Cervantes A, Paz-Ares L, Cort\u00e9s-Funes H: Phase III study comparing cisplatin plus fluorouracil to paclitxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2005, 23: 8636-8645. 10.1200\/JCO.2004.00.1990.","journal-title":"J Clin Oncol"},{"key":"2675_CR29","volume-title":"Proc ASCO","author":"R Hitt","year":"2009","unstructured":"Hitt R, Grau JJ, Lopez-Pousa A, Berrocal A, Garcia Giron C, Irigoyen A, Sastre J, Martinez J, Cortes-Funes H, Cruz-Hernandez J: Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin\/5-FU or docetaxel\/cisplatin\/5-FU followed by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC). Proc ASCO. 2009, abstr.# 6009"},{"key":"2675_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RA, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000, 92: 205-216. 10.1093\/jnci\/92.3.205.","journal-title":"J Natl Cancer Inst"},{"key":"2675_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Ass. 1958, 53: 457-481. 10.2307\/2281868.","journal-title":"J Am Stat Ass"},{"key":"2675_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0167-8140(00)00202-4","volume":"56","author":"V Gregoire","year":"2000","unstructured":"Gregoire V, Coche E, Cosnard G, Hamoir M, Reychler H: Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology ans procedure based on surgical experience. Radiother Oncol. 2000, 56: 135-150. 10.1016\/S0167-8140(00)00202-4.","journal-title":"Radiother Oncol"},{"key":"2675_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","volume":"69","author":"V Gregoire","year":"2003","unstructured":"Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, Chao C, Coche E, Cooper JS, Cosnard G, Eisbruch A, El-Sayed S, Emami B, Grau C, Hamoir M, Lee N, Maingon P, Muller K, Reychler H: CT-based delineation of lymph node levels and related CTVs in the node negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003, 69: 227-236. 10.1016\/j.radonc.2003.09.011.","journal-title":"Radiother Oncol"},{"key":"2675_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0360-3016(03)01453-6","volume":"58","author":"P Levendag","year":"2004","unstructured":"Levendag P, Braaksma M, Coche E, van Der Est H, Hamoir M, Muller K, Noever I, Nowak P, van S\u00f6rensen De Koste J, Gr\u00e9goire V: Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American academy of otolaryngology-head and neck surgery. Int J Radiat Oncol Biol Phys. 2004, 58: 113-123. 10.1016\/S0360-3016(03)01453-6.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2675_CR35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.ijrobp.2004.01.038","volume":"59","author":"I Poon","year":"2004","unstructured":"Poon I, Fischbein N, Lee N, Akazawa P, Xia P, Quivey J, Phillips T: A population-based atlas and clinical target volume for the head-and-neck lymph nodes. Int J Radiat Oncol Biol Phys. 2004, 59: 1301-1311. 10.1016\/j.ijrobp.2004.01.038.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2675_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/archotol.134.5.536","volume":"134","author":"KT Robbins","year":"2008","unstructured":"Robbins KT, Shaha AR, Medina JE, Califano JA, Wolf GT, Ferlito A, Som PM, Day TA: Committee for Neck Dissection Classification, American Head and Neck Society. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008, 134: 536-538. 10.1001\/archotol.134.5.536.","journal-title":"Arch Otolaryngol Head Neck Surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-182\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:25:15Z","timestamp":1497918315000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,19]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2675"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-182","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,19]]},"article-number":"182"}}